Shots:

• The US FDA has approved machine learning and AI-based Biofourmis’ Biovitals Analytics Engine as a medical device for ambulatory physiological monitoring 
• The approval follows the approval of its Rhythm Analytics platform- cloud-based software for automated interpretation of 15+ types of cardiac arrhythmias in May’2019. The approval establishes the AI-powered solution as the foundation for Biofourmis’ digital therapeutics product pipeline
• The Biovitals Analytics Engine within the context of the Biovitals HF platform helps to find the critical unmet medical needs in heart failure care

Click here to­ read full press release/ article | Ref: PRNewswire | Image: Pharmaceutical Technology